Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Study Shows Higher DHA Levels in Breast Milk Benefit Newborn Behavior
Study conducted at Texas Tech University, published in Journal of Pediatric Psychiatry revealed a positive correlation between DHA (docosahexaenoic acid) levels in breast milk and newborn neurobehavioral function.
- Study Shows Higher DHA Levels in Breast Milk Benefit Newborn Behavior
Study conducted at Texas Tech University, published in Journal of Pediatric Psychiatry revealed a positive correlation between DHA (docosahexaenoic acid) levels in breast milk and newborn neurobehavioral function.
- Study Shows Higher DHA Levels in Breast Milk Benefit Newborn Behavior
Study conducted at Texas Tech University, published in Journal of Pediatric Psychiatry revealed a positive correlation between DHA (docosahexaenoic acid) levels in breast milk and newborn neurobehavioral function.
- Nutrition Formulators, Inc and HCIS Laboratories To Offer Clinical Trial Services To the Nutraceutical Industry
Companies partner to offer sevices; trials wiill be conducted overseas; a US based Institutional Review Board will examine and approve study protocols.
- Nutrition Formulators, Inc and HCIS Laboratories To Offer Clinical Trial Services To the Nutraceutical Industry
Companies partner to offer sevices; trials wiill be conducted overseas; a US based Institutional Review Board will examine and approve study protocols.
- Nutrition Formulators, Inc and HCIS Laboratories To Offer Clinical Trial Services To the Nutraceutical Industry
Companies partner to offer sevices; trials wiill be conducted overseas; a US based Institutional Review Board will examine and approve study protocols.
- Nutrition Formulators, Inc and HCIS Laboratories To Offer Clinical Trial Services To the Nutraceutical Industry
Companies partner to offer sevices; trials wiill be conducted overseas; a US based Institutional Review Board will examine and approve study protocols.
- Two Seminal Studies Demonstrate Benefit of Glucosamine And Chondroitin In Osteoarthritis Patients
National Institutes of Health (NIH) trial shows effectiveness of glucosamine/chondroitin combination for moderate to severe pain, while multi-center European study favorably compares glucosamine to over-the-counter remedy for joint pain.
- Two Seminal Studies Demonstrate Benefit of Glucosamine And Chondroitin In Osteoarthritis Patients
National Institutes of Health (NIH) trial shows effectiveness of glucosamine/chondroitin combination for moderate to severe pain, while multi-center European study favorably compares glucosamine to over-the-counter remedy for joint pain.
- Two Seminal Studies Demonstrate Benefit of Glucosamine And Chondroitin In Osteoarthritis Patients
National Institutes of Health (NIH) trial shows effectiveness of glucosamine/chondroitin combination for moderate to severe pain, while multi-center European study favorably compares glucosamine to over-the-counter remedy for joint pain.
- Chromium Picolinate Linked With Reduced Carbohydrate Cravings in People With Atypical Depression
Randomized , double-blind, placebo-controlled study in 113 people with atypical depression , published in the Journal of Psychiatric Practice, finds that 65% of patients receving chromium picolinate supplementation with high carbohydrate craving, versus 33% of those receiving placebo, had significantly greater improvements in Hamilton Depression Rating Scale.
- Chromium Picolinate Linked With Reduced Carbohydrate Cravings in People With Atypical Depression
Randomized , double-blind, placebo-controlled study in 113 people with atypical depression , published in the Journal of Psychiatric Practice, finds that 65% of patients receving chromium picolinate supplementation with high carbohydrate craving, versus 33% of those receiving placebo, had significantly greater improvements in Hamilton Depression Rating Scale.
- Chromium Picolinate Linked With Reduced Carbohydrate Cravings in People With Atypical Depression
Randomized , double-blind, placebo-controlled study in 113 people with atypical depression , published in the Journal of Psychiatric Practice, finds that 65% of patients receving chromium picolinate supplementation with high carbohydrate craving, versus 33% of those receiving placebo, had significantly greater improvements in Hamilton Depression Rating Scale.
- Chromium Picolinate Linked With Reduced Carbohydrate Cravings in People With Atypical Depression
Randomized , double-blind, placebo-controlled study in 113 people with atypical depression , published in the Journal of Psychiatric Practice, finds that 65% of patients receving chromium picolinate supplementation with high carbohydrate craving, versus 33% of those receiving placebo, had significantly greater improvements in Hamilton Depression Rating Scale.
- The Solae Company Temporarily Withdraws FDA Health Claim Petition
Company temporarily withdraws its request for a qualified health claim related to soy protein consumption and cancer prevention, based on analysis of recent FDA health claim decisions; intends to re-structure petition to be more be in-line with FDA's current qualified health claim process.
- The Solae Company Temporarily Withdraws FDA Health Claim Petition
Company temporarily withdraws its request for a qualified health claim related to soy protein consumption and cancer prevention, based on analysis of recent FDA health claim decisions; intends to re-structure petition to be more be in-line with FDA's current qualified health claim process.
- The Solae Company Temporarily Withdraws FDA Health Claim Petition
Company temporarily withdraws its request for a qualified health claim related to soy protein consumption and cancer prevention, based on analysis of recent FDA health claim decisions; intends to re-structure petition to be more be in-line with FDA's current qualified health claim process.
- The Solae Company Temporarily Withdraws FDA Health Claim Petition
Company temporarily withdraws its request for a qualified health claim related to soy protein consumption and cancer prevention, based on analysis of recent FDA health claim decisions; intends to re-structure petition to be more be in-line with FDA's current qualified health claim process.
- The Solae Company Temporarily Withdraws FDA Health Claim Petition
Company temporarily withdraws its request for a qualified health claim related to soy protein consumption and cancer prevention, based on analysis of recent FDA health claim decisions; intends to re-structure petition to be more be in-line with FDA's current qualified health claim process.
- The Solae Company Temporarily Withdraws FDA Health Claim Petition
Company temporarily withdraws its request for a qualified health claim related to soy protein consumption and cancer prevention, based on analysis of recent FDA health claim decisions; intends to re-structure petition to be more be in-line with FDA's current qualified health claim process.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- ForsLean Improves Body Composition According to Study Published in the Journal of Obesity Research
Results in August 2005 Journal of Obesity Research indicate that that ForsLean(R) promotes favorable changes in body composition by significantly increasing lean body mass and decreasing body fat percentages.
- ForsLean Improves Body Composition According to Study Published in the Journal of Obesity Research
Results in August 2005 Journal of Obesity Research indicate that that ForsLean(R) promotes favorable changes in body composition by significantly increasing lean body mass and decreasing body fat percentages.
- ForsLean Improves Body Composition According to Study Published in the Journal of Obesity Research
Results in August 2005 Journal of Obesity Research indicate that that ForsLean(R) promotes favorable changes in body composition by significantly increasing lean body mass and decreasing body fat percentages.
- ForsLean Improves Body Composition According to Study Published in the Journal of Obesity Research
Results in August 2005 Journal of Obesity Research indicate that that ForsLean(R) promotes favorable changes in body composition by significantly increasing lean body mass and decreasing body fat percentages.
- Phytochemicals May Protect Cartilage, Prevent Pain in Joints
Johns Hopkins researchers, in a study published in the Proceedings of the National Academy of Sciences, have determined that certain phytochemicals found in cruciferous plants, including broccoli, boost the activity of helpful phase 2 enzymes which in turn, help protect tisue and prevent inflammation. The cell study involved adding thse inducers to a dish containing chondrocyte cells that are crucial to maintaining healthy joints, with the inducers apparently preventing the activation of the inflammatory COX-2 enzyme.
- Phytochemicals May Protect Cartilage, Prevent Pain in Joints
Johns Hopkins researchers, in a study published in the Proceedings of the National Academy of Sciences, have determined that certain phytochemicals found in cruciferous plants, including broccoli, boost the activity of helpful phase 2 enzymes which in turn, help protect tisue and prevent inflammation. The cell study involved adding thse inducers to a dish containing chondrocyte cells that are crucial to maintaining healthy joints, with the inducers apparently preventing the activation of the inflammatory COX-2 enzyme.
- Phytochemicals May Protect Cartilage, Prevent Pain in Joints
Johns Hopkins researchers, in a study published in the Proceedings of the National Academy of Sciences, have determined that certain phytochemicals found in cruciferous plants, including broccoli, boost the activity of helpful phase 2 enzymes which in turn, help protect tisue and prevent inflammation. The cell study involved adding thse inducers to a dish containing chondrocyte cells that are crucial to maintaining healthy joints, with the inducers apparently preventing the activation of the inflammatory COX-2 enzyme.
- Geni Herbs Announces PomElla® Clinical Study Plan
Current studies involving phase-2 human clinicals explore the in vivo effects of PomElla on heart disease risk factors in people with cardiovascular problems, as well as its in vivo antioxidant capacity and bioavailability. Research beginning in 2006 includes further studies exploring the mechanisms involved in optimizing cardio health with PomElla.
- Geni Herbs Announces PomElla® Clinical Study Plan
Current studies involving phase-2 human clinicals explore the in vivo effects of PomElla on heart disease risk factors in people with cardiovascular problems, as well as its in vivo antioxidant capacity and bioavailability. Research beginning in 2006 includes further studies exploring the mechanisms involved in optimizing cardio health with PomElla.
- Geni Herbs Announces PomElla® Clinical Study Plan
Current studies involving phase-2 human clinicals explore the in vivo effects of PomElla on heart disease risk factors in people with cardiovascular problems, as well as its in vivo antioxidant capacity and bioavailability. Research beginning in 2006 includes further studies exploring the mechanisms involved in optimizing cardio health with PomElla.
- AHPA Asks FDA, NCCAM to Portray Supplements Honestly
Association challenges the FDA and the National Center for Complementary and Alternative Medicine to tell the truth and to correct past misstatements about dietary supplements and echinacea products, respectively.
- AHPA Asks FDA, NCCAM to Portray Supplements Honestly
Association challenges the FDA and the National Center for Complementary and Alternative Medicine to tell the truth and to correct past misstatements about dietary supplements and echinacea products, respectively.
- AHPA Asks FDA, NCCAM to Portray Supplements Honestly
Association challenges the FDA and the National Center for Complementary and Alternative Medicine to tell the truth and to correct past misstatements about dietary supplements and echinacea products, respectively.
- AHPA Asks FDA, NCCAM to Portray Supplements Honestly
Association challenges the FDA and the National Center for Complementary and Alternative Medicine to tell the truth and to correct past misstatements about dietary supplements and echinacea products, respectively.
- AHPA Asks FDA, NCCAM to Portray Supplements Honestly
Association challenges the FDA and the National Center for Complementary and Alternative Medicine to tell the truth and to correct past misstatements about dietary supplements and echinacea products, respectively.
- AHPA Asks FDA, NCCAM to Portray Supplements Honestly
Association challenges the FDA and the National Center for Complementary and Alternative Medicine to tell the truth and to correct past misstatements about dietary supplements and echinacea products, respectively.
- Study Confirms BioLogic Health Solutions' MenoLogic (TM) Cream Reduces Menopause Symptoms
Company announces results of a 5-month Australian randomized, double-blind, placebo controlled study of 23 menopausal women, published in the International Journal of Naturopathic Medicine indicating that MenoLogic (TM) ingredient is effective in reducing symptoms associated with menopause.
- Study Confirms BioLogic Health Solutions' MenoLogic (TM) Cream Reduces Menopause Symptoms
Company announces results of a 5-month Australian randomized, double-blind, placebo controlled study of 23 menopausal women, published in the International Journal of Naturopathic Medicine indicating that MenoLogic (TM) ingredient is effective in reducing symptoms associated with menopause.
- Nexrutine® Shown Effective In New Open-Label Study
288 patients at the Living Longer Clinic in Cincinnati, OH participated in the study, of which 88% of the patients noted that the product reduced pain and/or inflammation and increased mobility and flexibility.
- Nexrutine® Shown Effective In New Open-Label Study
288 patients at the Living Longer Clinic in Cincinnati, OH participated in the study, of which 88% of the patients noted that the product reduced pain and/or inflammation and increased mobility and flexibility.
- Sen. Durbin Introduces, Withdraws AER Amendment
Sen. Richard Durbin (D-Ill.) introduced and promptly withdrew an amendment to the Defense Authorization Act that would have prohibited the sale of certain dietary supplements on military bases if manufacturers did not have a system to report adverse events to the government.
- Sen. Durbin Introduces, Withdraws AER Amendment
Sen. Richard Durbin (D-Ill.) introduced and promptly withdrew an amendment to the Defense Authorization Act that would have prohibited the sale of certain dietary supplements on military bases if manufacturers did not have a system to report adverse events to the government.
- NCCAM Revises Report of Echinacea Study, Notes Criticism of Low Dose
The National Center for Complementary and Alternative Medicine has revised its website to correct erroneous statements it had made previously about a study on low-dose preparations of Echinacea angustifolia root published in the New England Journal of Medicine on July 28, 2005.
- NCCAM Revises Report of Echinacea Study, Notes Criticism of Low Dose
The National Center for Complementary and Alternative Medicine has revised its website to correct erroneous statements it had made previously about a study on low-dose preparations of Echinacea angustifolia root published in the New England Journal of Medicine on July 28, 2005.
- Study Finds Cranberries Have Novel Bacteria-Blocking Benefits
Rutgers University research, published in the current issue of Phytochemistry, indicates that cranberry juice cocktail exhibited anti-adhesion activity following a single serving, based on activity of its natural condensed tannins, called proanthocyanidins, or PACs; cranberry contains unusual A-type PAC linkage.
- Study Finds Cranberries Have Novel Bacteria-Blocking Benefits
Rutgers University research, published in the current issue of Phytochemistry, indicates that cranberry juice cocktail exhibited anti-adhesion activity following a single serving, based on activity of its natural condensed tannins, called proanthocyanidins, or PACs; cranberry contains unusual A-type PAC linkage.
- Study Finds Cranberries Have Novel Bacteria-Blocking Benefits
Rutgers University research, published in the current issue of Phytochemistry, indicates that cranberry juice cocktail exhibited anti-adhesion activity following a single serving, based on activity of its natural condensed tannins, called proanthocyanidins, or PACs; cranberry contains unusual A-type PAC linkage.
- Study Finds Cranberries Have Novel Bacteria-Blocking Benefits
Rutgers University research, published in the current issue of Phytochemistry, indicates that cranberry juice cocktail exhibited anti-adhesion activity following a single serving, based on activity of its natural condensed tannins, called proanthocyanidins, or PACs; cranberry contains unusual A-type PAC linkage.
- Burcon Announces Technology Advancements - Expands Protein Applications
Company announces that it has successfully developed modifications to its patented protein extraction process that improve the physical and functional properties of Puratein(R) and Supertein(TM) which is expected to enable their use in a broader array of food and beverage applications.
- Burcon Announces Technology Advancements - Expands Protein Applications
Company announces that it has successfully developed modifications to its patented protein extraction process that improve the physical and functional properties of Puratein(R) and Supertein(TM) which is expected to enable their use in a broader array of food and beverage applications.
- Prebiotic Ingredient Raftilose® Helps Create Low GI Products
new study from Leatherhead Food International has shown that Raftilose®, the prebiotic ingredient from ORAFTI, can significantly lower the glycemic index of food products, when used in replacement for sugar.
- Prebiotic Ingredient Raftilose® Helps Create Low GI Products
new study from Leatherhead Food International has shown that Raftilose®, the prebiotic ingredient from ORAFTI, can significantly lower the glycemic index of food products, when used in replacement for sugar.
- Prebiotic Ingredient Raftilose® Helps Create Low GI Products
new study from Leatherhead Food International has shown that Raftilose®, the prebiotic ingredient from ORAFTI, can significantly lower the glycemic index of food products, when used in replacement for sugar.
- Prebiotic Ingredient Raftilose® Helps Create Low GI Products
new study from Leatherhead Food International has shown that Raftilose®, the prebiotic ingredient from ORAFTI, can significantly lower the glycemic index of food products, when used in replacement for sugar.
- Prebiotic Ingredient Raftilose® Helps Create Low GI Products
new study from Leatherhead Food International has shown that Raftilose®, the prebiotic ingredient from ORAFTI, can significantly lower the glycemic index of food products, when used in replacement for sugar.
- Prebiotic Ingredient Raftilose® Helps Create Low GI Products
new study from Leatherhead Food International has shown that Raftilose®, the prebiotic ingredient from ORAFTI, can significantly lower the glycemic index of food products, when used in replacement for sugar.
- Yale Study Reaffirms Link Between Dark Chocolate and Cardiovascular Benefits
Latest study used ultrasound technology and sophisticated measurements to assess the effects of eating high-cacao content dark chocolate, Hershey's(R) Extra Dark, on the arterial function of 45 moderately overweight adults, subjects' blood pressure before and two hours after eating two servings (74 grams) of dark chocolate, demonstrating improvements in blood pressure, as well as the ability of blood vessels to dilate and increase flow.
- Yale Study Reaffirms Link Between Dark Chocolate and Cardiovascular Benefits
Latest study used ultrasound technology and sophisticated measurements to assess the effects of eating high-cacao content dark chocolate, Hershey's(R) Extra Dark, on the arterial function of 45 moderately overweight adults, subjects' blood pressure before and two hours after eating two servings (74 grams) of dark chocolate, demonstrating improvements in blood pressure, as well as the ability of blood vessels to dilate and increase flow.
- Yale Study Reaffirms Link Between Dark Chocolate and Cardiovascular Benefits
Latest study used ultrasound technology and sophisticated measurements to assess the effects of eating high-cacao content dark chocolate, Hershey's(R) Extra Dark, on the arterial function of 45 moderately overweight adults, subjects' blood pressure before and two hours after eating two servings (74 grams) of dark chocolate, demonstrating improvements in blood pressure, as well as the ability of blood vessels to dilate and increase flow.
- Yale Study Reaffirms Link Between Dark Chocolate and Cardiovascular Benefits
Latest study used ultrasound technology and sophisticated measurements to assess the effects of eating high-cacao content dark chocolate, Hershey's(R) Extra Dark, on the arterial function of 45 moderately overweight adults, subjects' blood pressure before and two hours after eating two servings (74 grams) of dark chocolate, demonstrating improvements in blood pressure, as well as the ability of blood vessels to dilate and increase flow.
- Study Indicates That Relora® Significantly Reduces Stress, Anxiety and Sleep Latency
Findings presented at the WorldNutra Conference indicate in randomized, placebo-controlled, parallel-group, clinical trial of 40 healthy, overweight, physically active, 25-50 year old women , that Spielberger Trait Total and Anxiety Index scores improved significantly and Relora group had twice as much average reduction in sleep latency as the placebo group.
- Study Indicates That Relora® Significantly Reduces Stress, Anxiety and Sleep Latency
Findings presented at the WorldNutra Conference indicate in randomized, placebo-controlled, parallel-group, clinical trial of 40 healthy, overweight, physically active, 25-50 year old women , that Spielberger Trait Total and Anxiety Index scores improved significantly and Relora group had twice as much average reduction in sleep latency as the placebo group.
- Study Indicates That Relora® Significantly Reduces Stress, Anxiety and Sleep Latency
Findings presented at the WorldNutra Conference indicate in randomized, placebo-controlled, parallel-group, clinical trial of 40 healthy, overweight, physically active, 25-50 year old women , that Spielberger Trait Total and Anxiety Index scores improved significantly and Relora group had twice as much average reduction in sleep latency as the placebo group.
- Study Indicates That Relora® Significantly Reduces Stress, Anxiety and Sleep Latency
Findings presented at the WorldNutra Conference indicate in randomized, placebo-controlled, parallel-group, clinical trial of 40 healthy, overweight, physically active, 25-50 year old women , that Spielberger Trait Total and Anxiety Index scores improved significantly and Relora group had twice as much average reduction in sleep latency as the placebo group.
- Dietary Fat Intake Linked to Dry Eye Syndrome in Women
Study, published in the October 2005 issue of the American Journal of Clinical Nutrition indicates that women with the highest levels of omega 3 in their diets reduced their risk of dry eye syndrome by 20 percent compared to women with the lowest levels of this fat in their diet and that a dietary ratio of omega 6 to omega 3 greater than 15:1 was associated with a 2.5-fold increased risk of dry eye syndrome in women.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
EDINA, MN – Minnesota Applied Research Center (MARC) announced the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer. In addition, MARC added new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine.
The portable PASSPORT Monitors (Datascope Corp., Paramus, NJ) measure ECG, blood pressure, pulse oximetry, respiration rate and temperature. The two new TRUE ONE® Metabolic Measurement Systems (ParvoMedics, Inc., Sandy, UT) measure respired carbon dioxide and oxygen consumption with computerized analytical programs designed to assess indirect calorimetry parameters including total energy expenditure and resting metabolic rate. This technology is used for athletic testing, energy/nutritional assessment, exercise physiology, sports medicine/rehabilitation, and cardiopulmonary testing.
 The new Lunar Prodigy Advance Plus DXA scanner (GE Healthcare, Madison, WI) is considered a “gold standard” for measuring bone mineral density, diagnosing osteoporosis and following bone density over time. Of interest to the weight loss community, this instrument can also measure total body composition including accurate and objective
(more)
assessments of individual fat, lean and bone tissues. The full body DXA scan provides measures in gram amounts and total body percentages for body fat, lean and bone tissues. This is an excellent tool to assess weight loss therapies, fitness programs, sports medicines, endocrine/growth disorders and osteoporosis. For MARC weight loss trials, DXA scans are taken before and after a diet program protocol designed to assess the success of using natural products in combination with calorie reduction and exercise for fat loss and lean muscle preservation.
“Many of our clients, customers, and sponsors are interested in weight loss and the benefits that natural products bring to address the international epidemic in obesity” says Joy Frestedt, PhD, Executive Director of Research, Minnesota Applied Research Center. “This expansion is timely as the US, European and international regulations are becoming more defined for the substantiation needed for claims about natural products. We are excited to be growing and expanding to address the need for excellent clinical research in many areas including the area of weight management and the use of natural products.”
About MARC
The Minnesota Applied Research Center (MARC) is a fully equipped clinical research facility with the ability to take a research idea from conception to completion. MARC provides professional, timely and cost effective clinical trials for the dietary supplement, pharmaceutical, and medical device industries. In addition, MARC provides consulting services for the design and conduct of clinical trials, the review and monitoring of ongoing trials, and the documentation and submission of trial results for publication or claims support. MARC is based in Edina, Minnesota and can be reached at 952-974-4370 or www.onthemarcresearch.com.
# # #
CONTACT:
Joy Frestedt, PhD, Executive Director of Research
Minnesota Applied Research Center
952-974-4370 x 232
jfrestedt@onthemarcresearch.com
|